Health Canada

Health Canada

July 13, 2010 10:31 ET

Health Canada: Note to Editors

OTTAWA, ONTARIO--(Marketwire - July 13, 2010) - Health Canada today released the July 2010 issue of the Canadian Adverse Reaction Newsletter (CARN).

This issue includes an article on pregabalin (marketed as Lyrica) and a suspected association with suicidal thoughts and behaviours. Pregabalin is a prescription drug used in the treatment of pain.

It also contains an article on adverse reactions suspected of being associated with injectable hyaluronic acid (HA) dermal fillers, which are used to correct facial wrinkles.

Finally, the newsletter contains an article on a suspected association between oral iron supplements, and serious skin and allergic reactions. A quarterly summary of health professional and consumer advisories is also included.

The July 2010 edition of CARN can be viewed on the Health Canada Web site at:

Contact Information

  • Media Inquiries:
    Health Canada
    Media Relations